MA33743B1 - Compositions comprenant du tramadol et du célécoxib dans le traitement de la douleur - Google Patents
Compositions comprenant du tramadol et du célécoxib dans le traitement de la douleurInfo
- Publication number
- MA33743B1 MA33743B1 MA34860A MA34860A MA33743B1 MA 33743 B1 MA33743 B1 MA 33743B1 MA 34860 A MA34860 A MA 34860A MA 34860 A MA34860 A MA 34860A MA 33743 B1 MA33743 B1 MA 33743B1
- Authority
- MA
- Morocco
- Prior art keywords
- tramadol
- celecoxib
- treatment
- pain
- combinations
- Prior art date
Links
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title abstract 2
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000590 celecoxib Drugs 0.000 title abstract 2
- 229960004380 tramadol Drugs 0.000 title abstract 2
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09384004A EP2311446A1 (en) | 2009-10-16 | 2009-10-16 | Compositions comprising Tramadol and Celecoxib in the treatment of pain |
| PCT/EP2010/006317 WO2011045075A1 (en) | 2009-10-16 | 2010-10-15 | Compositions comprising tramadol and celecoxib in the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA33743B1 true MA33743B1 (fr) | 2012-11-01 |
Family
ID=41566149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34860A MA33743B1 (fr) | 2009-10-16 | 2012-05-11 | Compositions comprenant du tramadol et du célécoxib dans le traitement de la douleur |
Country Status (33)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2177215A1 (en) | 2008-10-17 | 2010-04-21 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of tramadol and NSAIDs |
| US8746719B2 (en) * | 2010-08-03 | 2014-06-10 | Polaris Industries Inc. | Side-by-side vehicle |
| CN107982211A (zh) * | 2011-04-05 | 2018-05-04 | 奥普托索夫研究与发展有限公司 | 眼科治疗 |
| PT2965759T (pt) * | 2012-02-06 | 2020-02-07 | Innovative Med Concepts Llc | Composto antiviral e inibidor e terapia de combinação do inibidor de cox-2 para fibromialgia |
| WO2016116942A1 (en) | 2015-01-20 | 2016-07-28 | Anlon Chemical Research Organization | Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin |
| CN107847437B (zh) * | 2015-05-28 | 2024-03-26 | 瑞迪博士实验室有限公司 | 用于治疗疼痛的塞来昔布口服组合物 |
| KR101710792B1 (ko) | 2015-07-14 | 2017-02-28 | 주식회사 유영제약 | 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물 |
| MX2016006464A (es) * | 2016-05-18 | 2017-11-17 | Laboratorios Liomont S A De C V | Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor. |
| CN119055585A (zh) * | 2016-05-27 | 2024-12-03 | 雷迪博士实验室有限公司 | 用于治疗疼痛的塞来昔布口服组合物 |
| US20200323780A1 (en) * | 2017-04-03 | 2020-10-15 | Kims Healthcare Co., Ltd. | Bilayer combination tablet for oral administration containing tramadol and celecoxib |
| WO2018186650A2 (ko) * | 2017-04-03 | 2018-10-11 | 주식회사 킴스헬스케어 | 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제 |
| KR102631399B1 (ko) | 2018-03-30 | 2024-02-01 | 씨지인바이츠 주식회사 | 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물 |
| KR20220008301A (ko) * | 2019-05-14 | 2022-01-20 | 에스테베 파마슈티칼스 에스에이 | 트라마돌의 남용 경향을 감소시키면서 통증을 치료하기 위한 트라마돌과 세레콕시브의 공-결정의 용도 |
| CN112007024A (zh) * | 2019-05-28 | 2020-12-01 | 江苏恒瑞医药股份有限公司 | 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途 |
| CA3144079A1 (en) | 2020-12-28 | 2022-06-28 | Biodelivery Sciences International, Inc. | Methods of treating pain |
| WO2025125888A1 (en) * | 2023-12-15 | 2025-06-19 | Centro De Investigación Y De Estudios Avanzados Del I.P.N. | Aripiprazole and tramadol compositions with potentiation effects and high analgesic efficacy useful for the treatment of neuropathic pain |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5516803A (en) | 1991-10-30 | 1996-05-14 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| AU661723B2 (en) | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
| EP1156855A1 (en) * | 1999-03-01 | 2001-11-28 | Ortho-McNeil Pharmaceutical, Inc. | Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| DE19927688A1 (de) | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
| US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| EP1478366B1 (en) * | 2002-02-19 | 2008-12-03 | Adcock Ingram Limited | Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol |
| US20080031950A1 (en) * | 2007-04-27 | 2008-02-07 | Nectid Inc. | Novel anelgesic combination |
| CN102573825B (zh) * | 2009-10-16 | 2015-04-22 | 埃斯蒂文博士实验室股份有限公司 | 曲马多与昔布类的共晶体 |
| EP2392319A1 (en) * | 2010-06-04 | 2011-12-07 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
-
2009
- 2009-10-16 EP EP09384004A patent/EP2311446A1/en not_active Withdrawn
-
2010
- 2010-10-14 TW TW99134996A patent/TWI466668B/zh active
- 2010-10-15 US US13/394,995 patent/US8569271B2/en active Active
- 2010-10-15 DK DK10765762.9T patent/DK2488170T3/en active
- 2010-10-15 PT PT107657629T patent/PT2488170E/pt unknown
- 2010-10-15 MY MYPI2012000614A patent/MY156275A/en unknown
- 2010-10-15 EP EP10765762.9A patent/EP2488170B1/en active Active
- 2010-10-15 SI SI201030545T patent/SI2488170T1/sl unknown
- 2010-10-15 CN CN2010800463605A patent/CN102573824A/zh active Pending
- 2010-10-15 KR KR1020127009600A patent/KR101688996B1/ko not_active Ceased
- 2010-10-15 IN IN1434DEN2012 patent/IN2012DN01434A/en unknown
- 2010-10-15 PL PL10765762T patent/PL2488170T3/pl unknown
- 2010-10-15 ES ES10765762.9T patent/ES2450615T3/es active Active
- 2010-10-15 EP EP13005822.5A patent/EP2737898A1/en not_active Withdrawn
- 2010-10-15 HR HRP20140157AT patent/HRP20140157T1/hr unknown
- 2010-10-15 AU AU2010306114A patent/AU2010306114B2/en active Active
- 2010-10-15 SG SG2012010898A patent/SG178833A1/en unknown
- 2010-10-15 RU RU2016125895A patent/RU2707752C2/ru active
- 2010-10-15 BR BR112012005044A patent/BR112012005044B8/pt active IP Right Grant
- 2010-10-15 AR ARP100103776A patent/AR078653A1/es not_active Application Discontinuation
- 2010-10-15 RU RU2012120087/15A patent/RU2012120087A/ru unknown
- 2010-10-15 NZ NZ598361A patent/NZ598361A/en unknown
- 2010-10-15 CA CA2771651A patent/CA2771651C/en active Active
- 2010-10-15 WO PCT/EP2010/006317 patent/WO2011045075A1/en not_active Ceased
- 2010-10-15 MX MX2012003051A patent/MX2012003051A/es active IP Right Grant
- 2010-10-15 JP JP2012533530A patent/JP5579858B2/ja active Active
- 2010-10-15 RS RS20140100A patent/RS53202B/sr unknown
- 2010-10-15 CN CN201611195215.9A patent/CN107050006A/zh active Pending
- 2010-10-15 UA UAA201205897A patent/UA108213C2/uk unknown
-
2012
- 2012-02-10 TN TNP2012000059A patent/TN2012000059A1/en unknown
- 2012-02-14 IL IL218096A patent/IL218096A/en active IP Right Grant
- 2012-03-16 CO CO12046133A patent/CO6511249A2/es active IP Right Grant
- 2012-03-19 EC ECSP12011735 patent/ECSP12011735A/es unknown
- 2012-03-23 ZA ZA2012/02151A patent/ZA201202151B/en unknown
- 2012-05-11 MA MA34860A patent/MA33743B1/fr unknown
-
2013
- 2013-09-25 US US14/036,828 patent/US20140024622A1/en not_active Abandoned
-
2014
- 2014-03-10 CY CY20141100195T patent/CY1114960T1/el unknown
- 2014-03-20 SM SM201400035T patent/SMT201400035B/xx unknown
- 2014-07-09 JP JP2014141720A patent/JP2014221797A/ja not_active Withdrawn
-
2015
- 2015-02-04 US US14/613,475 patent/US20150150889A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA33743B1 (fr) | Compositions comprenant du tramadol et du célécoxib dans le traitement de la douleur | |
| MA32397B1 (fr) | Agonistes mixtes basés sur gip destinés au traitement de troubles métaboliques et de l'obésité | |
| MA32099B1 (fr) | Composition comprenant un anticorps se liant au domaine ii de her2 et variantes acides de celle-ci | |
| MA38144A1 (fr) | Compositions et procédés pour le traitement de protéinopathies | |
| MA39094A1 (fr) | Polythérapie comprenant un inhibiteur de mdm2 et un ou plusieurs principes pharmaceutiquement actifs supplémentaires pour le traitement de cancers | |
| MA37963A1 (fr) | Protéines de fusion pour traiter un syndrome métabolique | |
| MA35458B1 (fr) | Variants du facteur de croissance des fibroblastes 21 | |
| TNSN07305A1 (fr) | Agonistes de pyy et leurs utilisations | |
| EA200802166A1 (ru) | Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью | |
| BR112015007985A2 (pt) | compostos do carboidrato galactose denteada para o tratamento de nefropatia diabética e distúrbios associados | |
| FR3028753B1 (fr) | Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application | |
| EP2473045A4 (en) | Niacin FATTY ACID CONJUGATES AND USES THEREOF | |
| MA34555B1 (fr) | Nouvelles protéines de liaison à un antigène | |
| MX2011000255A (es) | Combinacion de un antagonista a c-met y un compuesto aminoheteroarilo, para el tratamiento de cancer. | |
| MY167918A (en) | Composition for use in the sublingual delivery of medicaments to humans | |
| UA99540C2 (ru) | Замещенные мостиковым хиноксалином пиперидиновые соединения и их применение | |
| MX340985B (es) | Compuestos de n-heteroarilo. | |
| FR3034993B1 (fr) | Conditionnement unitaire, compositions et schemas therapeutiques pour l'administration de stimulateurs des voies de pro-resolution sur des surfaces keratiniques | |
| MA38810B1 (fr) | Inhibiteurs de rorc2 méthodes d'utilisation associées | |
| BRPI0710682B8 (pt) | combinação farmacêutica compreendendo 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol e paracetamol | |
| FR3058059B1 (fr) | Composition pharmaceutique comprenant le beta-elemene, le lupeol et le 2-hydroxycinnamaldehyde et/ou le 2'-benzoyloxycinnalmaldehyde et/ou le beta-sitosterol et/ou la curcumine. | |
| EA201791225A1 (ru) | Композиции и способы применения солабегрона с модифицированным высвобождением при симптомах нижних мочевых путей | |
| MA38253B1 (fr) | Compositions comprenant de la vortioxétine et du donépézil | |
| FR2918988B1 (fr) | Extrait polysaccharidique de lentinus et compositions pharmaceutiques, cosmetiques ou nutraceutiques comprenant un tel extrait. | |
| FR2913885B1 (fr) | Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines |